Modifier gene study of meconium ileus in cystic fibrosis: Statistical considerations and gene mapping results

Ruslan Dorfman, Weili Li, Lei Sun, Fan Lin, Yongqian Wang, Andrew Sandford, Peter D. Paré, Karen McKay, Hana Kayserova, Tereza Piskackova, Milan MacEk, Kamila Czerska, Dorota Sands, Harm Tiddens, Sonia Margarit, Gabriela Repetto, Marci K. Sontag, Frank J. Accurso, Scott Blackman, Garry R. CuttingLap Chee Tsui, Mary Corey, Peter Durie, Julian Zielenski, Lisa J. Strug

Research output: Contribution to journalArticlepeer-review

Abstract

Cystic fibrosis (CF) is a monogenic disease due to mutations in the CFTR gene. Yet, variability in CF disease presentation is presumed to be affected by modifier genes, such as those recently demonstrated for the pulmonary aspect. Here, we conduct a modifier gene study for meconium ileus (MI), an intestinal obstruction that occurs in 16-20% of CF newborns, providing linkage and association results from large family and case-control samples. Linkage analysis of modifier traits is different than linkage analysis of primary traits on which a sample was ascertained. Here, we articulate a source of confounding unique to modifier gene studies and provide an example of how one might overcome the confounding in the context of linkage studies. Our linkage analysis provided evidence of a MI locus on chromosome 12p13.3, which was segregating in up to 80% of MI families with at least one affected offspring (HLOD = 2.9). Fine mapping of the 12p13.3 region in a large case-control sample of pancreatic insufficient Canadian CF patients with and without MI pointed to the involvement of ADIPOR2 in MI (p = 0.002). This marker was substantially out of Hardy-Weinberg equilibrium in the cases only, and provided evidence of a cohort effect. The association with rs9300298 in the ADIPOR2 gene at the 12p13.3 locus was replicated in an independent sample of CF families. A protective locus, using the phenotype of no-MI, mapped to 4q13.3 (HLOD = 3.19), with substantial heterogeneity. A candidate gene in the region, SLC4A4, provided preliminary evidence of association (p = 0.002), warranting further follow-up studies. Our linkage approach was used to direct our fine-mapping studies, which uncovered two potential modifier genes worthy of follow-up.

Original languageEnglish (US)
Pages (from-to)763-778
Number of pages16
JournalHuman genetics
Volume126
Issue number6
DOIs
StatePublished - Dec 2009

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Modifier gene study of meconium ileus in cystic fibrosis: Statistical considerations and gene mapping results'. Together they form a unique fingerprint.

Cite this